Oral Abstract Session:
37. Clinical Virology and Treatment
Friday, October 21, 2011: 8:45 AM-10:15 AM
Room: 156ABC

Topical Category: V. Virology including clinical and basic studies of viral infections, including hepatitis

Tracks: Adult ID, Pediatric ID, HIV

Moderators:  Marla Keller, MD, Albert Einstein College of Medicine and Ajit Limaye, MD, University of Washington

Presentations:

8:45 AM
138
Incidence of intrapartum hepatitis E virus infections in two large prospective cohorts of pregnant Bangladeshi women between 2001 and 2010
Alain Labrique, PhD, MHS, MSc, MACE ; Brittany Kmush, MS ; Ronald E. Engle, PhD ; Kerry Schulze, PhD ; Keith West, DrPH, RD ; Robert Purcell, PhD ; Kenrad Nelson, MD

9:00 AM
139
HHV-6 Reactivation and Associated Sequelae following Hematopoietic Cell Transplantation
Danielle Zerr, MD, MPH ; Michael Boeckh, MD, FIDSA ; Colleen Delaney, MD, MSc ; Paul Martin, MD ; Hu Xie, MSc ; Amanda Adler, BA ; Meei-Li Huang, PhD ; Larwrence Corey, MD ; Wendy Leisenring, ScD

9:15 AM
140
Lytic and Latent EBV Gene Expression in Transplant Recipients with and Without Post-Transplant  Lymphoproliferative Disorder
Jing Kroll, MD ; Shaobing Li, MD ; Marilyn Levi, MD ; Adriana Weinberg, MD

9:30 AM
141
Profiling of CMV-specific CD4 and CD8 Responses in Blood Identifies R+ Lung Transplant Patients (LTx Pts) Who Are Likely to Develop CMV Infection after Discontinuing Antiviral Prophylaxis (Px)
Cornelius Clancy, MD ; Cory Lutgen ; Jin Yu ; Jeff Hester, PhD ; Linda Flebbe-Rehwaldt ; D Mitsani, MD ; Ryan K. Shields, PharmD ; M. Hong Nguyen, MD

9:45 AM
142
Randomized, Double-Blind, Pilot Study of Nitazoxanide (NTZ) Versus Placebo (PCB) for the Treatment of Symptoms Associated with Viral Respiratory Infection (VRI) in Adults and Adolescents
Nicolas Lopez-Chegne, MD ; Luis-Martin Julcamoro, MD ; Jean-Francois Rossignol, MD, FRCPath, PhD, FRSC ; Maria Carrion, MD ; Matthew Bardin, PharmD, BCPS

10:00 AM
143
Safety and Pharmacokinetics of Acyclovir in Women Following Release from a Silicone Elastomer Vaginal Ring
Marla Keller, MD ; Amanda Malone, PhD ; John Moss, PhD ; Colleen Carpenter, BA ; Anna Lee, BA ; Erin Diament, FNP ; Robyn Willis, BS, GCPharmSc ; Marc Baum, PhD ; Betsy C. Herold, MD, FIDSA ; Thomas Smith, MD

CME Credits:

ACPE Credits:

ACPE Number:

Disclosures:

M. Keller, Auritec Pharmaceuticals, Inc: Investigator, Research support

A. Limaye, Amgen: Consultant, Consulting fee
Genentech: Consultant, Consulting fee
Vical: Consultant, Consulting fee
BioRad Laboratories: Consultant, Consulting fee

See more of: Oral Abstract Session
<< Previous Session | Next Session >>

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.